Risk factors related to pleural empyema after talc slurry pleurodesis

Detalhes bibliográficos
Autor(a) principal: D'Ambrosio, Paula Duarte
Data de Publicação: 2022
Outros Autores: Araújo, Pedro Henrique Xavier Nabuco de, Rocha Junior, Eserval, Razuk Filho, Mauro, Pêgo-Fernandes, Paulo Manuel, Terra, Ricardo Mingarini
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/213534
Resumo: Objective: Empyema is a complication of talc-pleurodesis that may lead to further surgical intervention and death. Therefore, the present study's objective was to identify the risk factors for the development of post-pleurodesis empyema after talc slurry pleurodesis in order to better select patients for this procedure and minimize its morbidity. Methods: Patients with malignant pleural effusion who underwent talc slurry pleurodesis at the present institution from January 2018 to January 2020 were retrospectively analyzed. Post-pleurodesis empyema was defined as pleural infection up to 30 days after pleurodesis. Using Cox regression analysis, significant prognostic factors for the development of empyema were examined. Results: Of the 86 patients identified for inclusion in the study, 62 were women (72%). Their mean age was 56.3±12.6 years. The median pleural drainage time was 9 days, and 20 patients (23.3%) developed empyema. In the univariate analysis, both drainage time (p = 0.038) and the use of antibiotics prior to pleurodesis (p < 0.001) were risk factors for pleural empyema. Multivariate analysis also identified the use of antibiotics as an independent risk factor (Odds Ratio [OR] 9.81; 95% Confidence Interval [95% CI] 2.87‒33.54). Although the pulmonary expansion was not associated with empyema in the multivariate analysis, patients with less than 50% pulmonary expansion had a 4.5-times increased risk of empyema (95% CI 0.90‒22.86; p = 0.067), and patients with 50‒70% pulmonary expansion had a 3.8-times increased risk of empyema (95% CI 0.98‒15; p = 0.053) after pleurodesis. Conclusion: The study suggests that antibiotic therapy prior to talc slurry pleurodesis may increase the risk of developing empyema. Furthermore, pleurodesis should be considered with caution in patients with long-duration chest tube placement and incomplete lung expansion.
id USP-19_d716bd86b6bee1cf2d5bb1b496ff2423
oai_identifier_str oai:revistas.usp.br:article/213534
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Risk factors related to pleural empyema after talc slurry pleurodesisEmpyemaPleurodesisPleural EffusionMalignancyObjective: Empyema is a complication of talc-pleurodesis that may lead to further surgical intervention and death. Therefore, the present study's objective was to identify the risk factors for the development of post-pleurodesis empyema after talc slurry pleurodesis in order to better select patients for this procedure and minimize its morbidity. Methods: Patients with malignant pleural effusion who underwent talc slurry pleurodesis at the present institution from January 2018 to January 2020 were retrospectively analyzed. Post-pleurodesis empyema was defined as pleural infection up to 30 days after pleurodesis. Using Cox regression analysis, significant prognostic factors for the development of empyema were examined. Results: Of the 86 patients identified for inclusion in the study, 62 were women (72%). Their mean age was 56.3±12.6 years. The median pleural drainage time was 9 days, and 20 patients (23.3%) developed empyema. In the univariate analysis, both drainage time (p = 0.038) and the use of antibiotics prior to pleurodesis (p < 0.001) were risk factors for pleural empyema. Multivariate analysis also identified the use of antibiotics as an independent risk factor (Odds Ratio [OR] 9.81; 95% Confidence Interval [95% CI] 2.87‒33.54). Although the pulmonary expansion was not associated with empyema in the multivariate analysis, patients with less than 50% pulmonary expansion had a 4.5-times increased risk of empyema (95% CI 0.90‒22.86; p = 0.067), and patients with 50‒70% pulmonary expansion had a 3.8-times increased risk of empyema (95% CI 0.98‒15; p = 0.053) after pleurodesis. Conclusion: The study suggests that antibiotic therapy prior to talc slurry pleurodesis may increase the risk of developing empyema. Furthermore, pleurodesis should be considered with caution in patients with long-duration chest tube placement and incomplete lung expansion.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2022-08-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21353410.1016/j.clinsp.2022.100098Clinics; Vol. 77 (2022); 100098Clinics; v. 77 (2022); 100098Clinics; Vol. 77 (2022); 1000981980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/213534/195625Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessD'Ambrosio, Paula DuarteAraújo, Pedro Henrique Xavier Nabuco deRocha Junior, EservalRazuk Filho, MauroPêgo-Fernandes, Paulo ManuelTerra, Ricardo Mingarini2023-07-06T13:04:58Zoai:revistas.usp.br:article/213534Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:04:58Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Risk factors related to pleural empyema after talc slurry pleurodesis
title Risk factors related to pleural empyema after talc slurry pleurodesis
spellingShingle Risk factors related to pleural empyema after talc slurry pleurodesis
D'Ambrosio, Paula Duarte
Empyema
Pleurodesis
Pleural Effusion
Malignancy
title_short Risk factors related to pleural empyema after talc slurry pleurodesis
title_full Risk factors related to pleural empyema after talc slurry pleurodesis
title_fullStr Risk factors related to pleural empyema after talc slurry pleurodesis
title_full_unstemmed Risk factors related to pleural empyema after talc slurry pleurodesis
title_sort Risk factors related to pleural empyema after talc slurry pleurodesis
author D'Ambrosio, Paula Duarte
author_facet D'Ambrosio, Paula Duarte
Araújo, Pedro Henrique Xavier Nabuco de
Rocha Junior, Eserval
Razuk Filho, Mauro
Pêgo-Fernandes, Paulo Manuel
Terra, Ricardo Mingarini
author_role author
author2 Araújo, Pedro Henrique Xavier Nabuco de
Rocha Junior, Eserval
Razuk Filho, Mauro
Pêgo-Fernandes, Paulo Manuel
Terra, Ricardo Mingarini
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv D'Ambrosio, Paula Duarte
Araújo, Pedro Henrique Xavier Nabuco de
Rocha Junior, Eserval
Razuk Filho, Mauro
Pêgo-Fernandes, Paulo Manuel
Terra, Ricardo Mingarini
dc.subject.por.fl_str_mv Empyema
Pleurodesis
Pleural Effusion
Malignancy
topic Empyema
Pleurodesis
Pleural Effusion
Malignancy
description Objective: Empyema is a complication of talc-pleurodesis that may lead to further surgical intervention and death. Therefore, the present study's objective was to identify the risk factors for the development of post-pleurodesis empyema after talc slurry pleurodesis in order to better select patients for this procedure and minimize its morbidity. Methods: Patients with malignant pleural effusion who underwent talc slurry pleurodesis at the present institution from January 2018 to January 2020 were retrospectively analyzed. Post-pleurodesis empyema was defined as pleural infection up to 30 days after pleurodesis. Using Cox regression analysis, significant prognostic factors for the development of empyema were examined. Results: Of the 86 patients identified for inclusion in the study, 62 were women (72%). Their mean age was 56.3±12.6 years. The median pleural drainage time was 9 days, and 20 patients (23.3%) developed empyema. In the univariate analysis, both drainage time (p = 0.038) and the use of antibiotics prior to pleurodesis (p < 0.001) were risk factors for pleural empyema. Multivariate analysis also identified the use of antibiotics as an independent risk factor (Odds Ratio [OR] 9.81; 95% Confidence Interval [95% CI] 2.87‒33.54). Although the pulmonary expansion was not associated with empyema in the multivariate analysis, patients with less than 50% pulmonary expansion had a 4.5-times increased risk of empyema (95% CI 0.90‒22.86; p = 0.067), and patients with 50‒70% pulmonary expansion had a 3.8-times increased risk of empyema (95% CI 0.98‒15; p = 0.053) after pleurodesis. Conclusion: The study suggests that antibiotic therapy prior to talc slurry pleurodesis may increase the risk of developing empyema. Furthermore, pleurodesis should be considered with caution in patients with long-duration chest tube placement and incomplete lung expansion.
publishDate 2022
dc.date.none.fl_str_mv 2022-08-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/213534
10.1016/j.clinsp.2022.100098
url https://www.revistas.usp.br/clinics/article/view/213534
identifier_str_mv 10.1016/j.clinsp.2022.100098
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/213534/195625
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 77 (2022); 100098
Clinics; v. 77 (2022); 100098
Clinics; Vol. 77 (2022); 100098
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222766679457792